SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova soars on acquiring 19.89% stake in O2 Renewable Energy XVI

07 Jun 2024 Evaluate

Jubilant Pharmova is currently trading at Rs. 742.35, up by 21.70 points or 3.01% from its previous closing of Rs. 720.65 on the BSE.

The scrip opened at Rs. 716.00 and has touched a high and low of Rs. 752.75 and Rs. 716.00 respectively. So far 25482 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 752.75 on 07-June-2024 and a 52 week low of Rs. 319.30 on 26-Oct-2023.

Last one week high and low of the scrip stood at Rs. 752.75 and Rs. 616.85 respectively. The current market cap of the company is Rs. 11804.33 crore.

The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 22.83% and 26.49% respectively.

Jubilant Pharmova has completed acquisition of 19.89% stake in O2 Renewable Energy XVI (O2) i.e. 75,903 Compulsory Convertible Debentures (CCDs) of face value of Rs 1,000 each and 8,43,362 Equity shares of face value of Rs 10 each. On March 29, 2024, the company had acquired 64,517 CCDs and 7,16,857 equity shares in O2. 

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.


Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×